FI882360A0 - Menetelmä terapeuttisesti käyttökelpoisten -(fluorimetyleeni)-5-hydroksitryptofaanijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten -(fluorimetyleeni)-5-hydroksitryptofaanijohdannaisten valmistamiseksi

Info

Publication number
FI882360A0
FI882360A0 FI882360A FI882360A FI882360A0 FI 882360 A0 FI882360 A0 FI 882360A0 FI 882360 A FI882360 A FI 882360A FI 882360 A FI882360 A FI 882360A FI 882360 A0 FI882360 A0 FI 882360A0
Authority
FI
Finland
Prior art keywords
fluoromethylene
hydroxytryptophan
derivatives
preparation
therapeutically useful
Prior art date
Application number
FI882360A
Other languages
English (en)
Swedish (sv)
Other versions
FI90531C (fi
FI882360A (fi
FI90531B (fi
Inventor
Ian A Mcdonald
Michael G Palfreyman
Jean-Noel Collard
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI882360A0 publication Critical patent/FI882360A0/fi
Publication of FI882360A publication Critical patent/FI882360A/fi
Application granted granted Critical
Publication of FI90531B publication Critical patent/FI90531B/fi
Publication of FI90531C publication Critical patent/FI90531C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI882360A 1987-05-21 1988-05-19 Menetelmä terapeuttisesti käyttökelpoisten -(fluorimetyleeni)-5-hydroksitryptofaanijohdannaisten valmistamiseksi FI90531C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5321287 1987-05-21
US07/053,212 US4822812A (en) 1987-05-21 1987-05-21 β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition

Publications (4)

Publication Number Publication Date
FI882360A0 true FI882360A0 (fi) 1988-05-19
FI882360A FI882360A (fi) 1988-11-22
FI90531B FI90531B (fi) 1993-11-15
FI90531C FI90531C (fi) 1994-02-25

Family

ID=21982670

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882360A FI90531C (fi) 1987-05-21 1988-05-19 Menetelmä terapeuttisesti käyttökelpoisten -(fluorimetyleeni)-5-hydroksitryptofaanijohdannaisten valmistamiseksi

Country Status (17)

Country Link
US (1) US4822812A (fi)
EP (1) EP0291998A3 (fi)
JP (1) JP2520285B2 (fi)
KR (1) KR960016521B1 (fi)
CN (1) CN1031222A (fi)
AR (1) AR246952A1 (fi)
AU (1) AU605865B2 (fi)
CA (1) CA1310973C (fi)
DK (1) DK169330B1 (fi)
FI (1) FI90531C (fi)
HU (2) HU199790B (fi)
IL (1) IL86387A0 (fi)
NO (1) NO172576C (fi)
NZ (1) NZ224661A (fi)
PH (1) PH25384A (fi)
PT (1) PT87538B (fi)
ZA (1) ZA883442B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
ITRM20020255A1 (it) * 2002-05-09 2003-11-10 Polifarma Spa Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.
US6972014B2 (en) * 2003-01-04 2005-12-06 Endocare, Inc. Open system heat exchange catheters and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2513597B2 (de) * 1975-03-27 1977-06-02 L-5-hydroxytryptophan-l-glutamatmonohydrat, verfahren zu seiner herstellung und arzneimittel
US4183858A (en) * 1977-07-01 1980-01-15 Merrell Toraude Et Compagnie α-Vinyl tryptophanes
FR2499076A1 (fr) * 1981-02-02 1982-08-06 Panmedica Laboratoires Nouveaux derives de l'acide ((indol-3 yl)-3 amino-2 propionyloxy)-2 acetique, procedes pour leur preparation et medicaments les contenant
US4421767A (en) * 1981-06-01 1983-12-20 Merrell Toraude Et Compagnie Compounds and methods for treating depression
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
ZA855101B (en) * 1984-07-13 1986-05-28 Merrell Dow Pharma Fluoroallylaine derivatives

Also Published As

Publication number Publication date
KR880013891A (ko) 1988-12-22
AU605865B2 (en) 1991-01-24
IL86387A0 (en) 1988-11-15
EP0291998A2 (en) 1988-11-23
AU1634788A (en) 1988-11-24
NZ224661A (en) 1990-08-28
NO882240L (no) 1988-11-22
HUT50117A (en) 1989-12-28
FI90531C (fi) 1994-02-25
JP2520285B2 (ja) 1996-07-31
AR246952A1 (es) 1994-10-31
NO882240D0 (no) 1988-05-20
NO172576B (no) 1993-05-03
PH25384A (en) 1991-06-03
US4822812A (en) 1989-04-18
EP0291998A3 (en) 1989-01-25
FI882360A (fi) 1988-11-22
DK278388D0 (da) 1988-05-20
IL86387A (fi) 1992-12-01
KR960016521B1 (ko) 1996-12-14
PT87538B (pt) 1992-09-30
NO172576C (no) 1993-08-11
JPS63303965A (ja) 1988-12-12
HUT47905A (en) 1989-04-28
CA1310973C (en) 1992-12-01
DK169330B1 (da) 1994-10-10
FI90531B (fi) 1993-11-15
HU199790B (en) 1990-03-28
ZA883442B (en) 1988-11-16
PT87538A (pt) 1989-05-31
CN1031222A (zh) 1989-02-22
DK278388A (da) 1988-11-22

Similar Documents

Publication Publication Date Title
FI883064A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI880941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI882638A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten booriaminohappojohdannaisten valmistamiseksi
FI880757A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tyydytettyjä heterosyklisiä karboksamidijohdoksia
FI95704B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
FI892881A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI850654A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
FI892182A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI94752C (fi) Menetelmä terapeuttisesti käyttökelpoisten propenonioksiimieettereiden valmistamiseksi
FI880869A (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI884910A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI873350A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI872769A (fi) Menetelmä alfa-mono-olefiinien polymeroimiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI891144A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.